BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4244949)

  • 1. Inhibition of phosphofructokinase by quinone methide and alpha-methylene lactone tumor inhibitors.
    Hanson RL; Lardy HA; Kupchan SM
    Science; 1970 Apr; 168(3929):378-80. PubMed ID: 4244949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Actions and interactions of substrates and effectors of phosphofructokinase from rabbit skeletal muscle].
    Hofer HW; Pette D
    Hoppe Seylers Z Physiol Chem; 1968 Oct; 349(10):1378-92. PubMed ID: 4235316
    [No Abstract]   [Full Text] [Related]  

  • 3. Taxodione and taxodone, two novel diterpenoid quinone methide tumor inhibitors from Taxodium distichum.
    Kupchan SM; Karim A; Marcks C
    J Am Chem Soc; 1968 Oct; 90(21):5923-4. PubMed ID: 5679178
    [No Abstract]   [Full Text] [Related]  

  • 4. [An allosteric enzyme with 2 substrates: phosphofructokinase from rat muscle. IV. Conjugated action of 2 allosteric inhibitors, ATP and citrate].
    Odeide R; Dupuis B; Guilloton M; Savany A; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1969 Dec; 51(7):1199-210. PubMed ID: 4243437
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivity of the sulfhydryl groups of muscle phosphofructokinase.
    Kemp RG; Forest PB
    Biochemistry; 1968 Jul; 7(7):2596-602. PubMed ID: 4232352
    [No Abstract]   [Full Text] [Related]  

  • 6. Allosteric properties of muscle phosphofructokinase. I. Binding of magnesium adenosine triphosphate to the inhibitory site.
    Kemp RG
    Biochemistry; 1969 Aug; 8(8):3162-8. PubMed ID: 4241302
    [No Abstract]   [Full Text] [Related]  

  • 7. Allosteric properties of muscle phosphofructokinase. II. Kinetics of native and thiol-modified enzyme.
    Kemp RG
    Biochemistry; 1969 Nov; 8(11):4490-6. PubMed ID: 4242847
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor inhibitors. 48. Taxodione and taxodone, two novel diterpenoid quinone methide tumor inhibitors from Taxodium distichum.
    Kupchan SM; Karim A; Marcks C
    J Org Chem; 1969 Dec; 34(12):3912-8. PubMed ID: 5357534
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivation of phosphofructokinase by 6-mercapto-9- -D-ribofuranosylpurine 5'-triphosphate.
    Bloxham DP; Clark MG; Holland PC; Lardy HA
    Biochemistry; 1973 Apr; 12(8):1596-601. PubMed ID: 4267013
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformational modification of muscle phosphofructokinase from Jaculus orientalis upon ligand binding.
    Tijane M; el Hachimi Z; Benjouad A; Desmadril M; Yon JM
    FEBS Lett; 1989 Mar; 245(1-2):30-4. PubMed ID: 2522395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influencing of the catalytic properties of phosphofructokinase by chemical modification of functionally important amino acids].
    Hofer HW
    Hoppe Seylers Z Physiol Chem; 1970 May; 351(5):649-57. PubMed ID: 4245966
    [No Abstract]   [Full Text] [Related]  

  • 12. Rabbit muscle phosphofructokinase. Reactivity and function of thiol groups.
    Younathan ES; Paetkau V; Lardy HA
    J Biol Chem; 1968 Apr; 243(7):1603-8. PubMed ID: 4231031
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of phosphofructokinase by the toxic cembranolide sarcophine isolated from the soft-bodied coral Sarcophyton glaucum.
    Erman A; NeƩman I
    Toxicon; 1977; 15(3):207-15. PubMed ID: 17178
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of an enzyme allosteric to 2 substrates: phosphofructokinases of rat muscle. II. Kinetic properties].
    Odeide R; Guilloton M; Dupuis B; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1968; 50(11):2035-52. PubMed ID: 4237773
    [No Abstract]   [Full Text] [Related]  

  • 15. Pihl A: Modification of regulatory properties of phosphofructokinase acetylation.
    Chapman A; Sanner T
    Eur J Biochem; 1969 Feb; 7(4):588-93. PubMed ID: 4237905
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on heart phosphofructokinase. Desensitization of the enzyme to adenosine triphosphate inhibition.
    Ahlfors CE; Mansour TE
    J Biol Chem; 1969 Mar; 244(5):1247-51. PubMed ID: 4237418
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple inhibitor sites for ATP on muscle phosphofructokinase as influenced by a change of pH: a computer analysis of "non-linear" kinetic data.
    Ui M
    Biochim Biophys Acta; 1968 Apr; 159(1):50-63. PubMed ID: 4231305
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific, reversible inactivation of phosphofructokinase by fructose-1,6-bisphosphatase. Involvement of adenosine 5'-triphosphate, oleate, and 3-phosphoglycerate.
    Proffitt RT; Sankaran L
    Biochemistry; 1976 Jun; 15(13):2918-25. PubMed ID: 181051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphofructokinase of Dictyostelium discoideum.
    Baumann P; Wright BE
    Biochemistry; 1968 Oct; 7(10):3653-61. PubMed ID: 4300706
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of the kinetic properties of phosphofructokinase by ammonium ions.
    Abrahams SL; Younathan ES
    J Biol Chem; 1971 Apr; 246(8):2464-7. PubMed ID: 4251852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.